|Day Low/High||61.31 / 64.50|
|52 Wk Low/High||63.01 / 101.24|
There is nothing better than digging for undiscovered gems and buying them.
Adam Feuerstein, senior columnist for TheStreet, says Sarepta Therapeutics is the next big thing to watch in biotech.
The market isn't in bad shape but, opportunities in individual names are limited.
Market players are adding long exposure as the market runs away from them.